Enlightenment Research’s Gilead Sciences GILD Stock Holding History

Enlightenment Research’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,000	Closed	-$581K	–	166
2021 Q4	$581K	Buy	8,000 +2,800	+54%	+$193K	0.83%	36
2021 Q3	$363K	Buy	+5,200	New	+$365K	0.44%	81
2021 Q2	–	Sell	-11,600	Closed	-$750K	–	164
2021 Q1	$750K	Buy	+11,600	New	+$748K	0.9%	30
2020 Q1	–	Sell	-8,100	Closed	-$526K	–	175
2019 Q4	$526K	Buy	8,100 +4,600	+131%	+$300K	2.46%	11
2019 Q3	$222K	Sell	3,500 -3,600	-51%	-$235K	0.49%	74
2019 Q2	$480K	Buy	+7,100	New	+$467K	0.24%	120
2019 Q1	–	Sell	-5,000	Closed	-$313K	–	323
2018 Q4	$313K	Buy	+5,000	New	+$349K	0.39%	55

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Enlightenment Research's GILD Position: Q1 2022 in Review

Enlightenment Research sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 8,000 shares — an estimated $581K sold.

Enlightenment Research first reported a position in GILD in Q4 2018 and held it in 7 quarters. The position peaked at $750K in Q1 2021. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

Enlightenment Research reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
Enlightenment Research sold 8,000 Gilead Sciences shares in Q1 2022, an estimated $581K.
Enlightenment Research first reported a position in Gilead Sciences in Q4 2018 and held it in 7 quarters.
Enlightenment Research's Gilead Sciences position peaked at $750K in Q1 2021.
1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Enlightenment Research's 13F filing for Q1 2022, filed 13 May 2022.